J. de Almeida Junior, “Medication change, from Natalizumab to Ocrelizumab, in a patient with relapsing-remitting multiple sclerosis: case report”, Braz. J. Implantol. Health Sci., vol. 6, no. 10, pp. 574–584, Oct. 2024.